About DIANT®
About DIANT®—Groundbreaking Nanoparticle Processing Systems for Optimal Yields, Quality and Control
Our Company
DIANT® Pharma, Inc., established in 2019, has introduced cutting-edge, end-to-end manufacturing platforms distinguished by its adaptability and seamlessly integrating nanoparticle generation with all downstream operations as a closed system. This innovative framework delivers a multitude of advantages, including a more compact production footprint, decreased facility requirements, heightened scalability, reduced human intervention, elimination of holding intervals, and precise regulation over particle size distribution. DIANT’s innovative blueprint for continuous nanoparticle production is predicated on an end-to-end manufacturing platform tailored for nucleic acid–LNPs, placing an emphasis on a closed-loop system design and exhaustive process monitoring protocols. The proprietary DIANT® Jet technology serves as the linchpin for efficient LNP generation through controlled mixing methodologies, ensuring the production of LNPs featuring unwavering uniformity, scalability across diverse applications, and exceptional particle characteristics.
Our Mission
Our mission is to transform the use of nanoparticles and LNPs in biopharmaceutical therapies by pioneering continuous and process-controlled manufacturing systems. We strive to enhance the speed, efficiency, and quality of nanoparticle processing, ultimately accelerating the time to market and supporting the industries for the better.
Our Team
Board of Directors
Our Partner
InProcess-LSP
InProcess-LSP’s groundbreaking work in Process Analytical Technology (PAT) led to the development of their NanoFlowSizer™, a non-invasive nanoparticle size maintenance system. DIANT is the only company that distributes the NanoFlowSizer™ in the U.S. and we have incorporated this real-time PAT into both the LiFT and LARU systems.
Our Work with the FDA
U.S. Food & Drug Administration (FDA)
We are proud to announce that the United States’ Food and Drug Administration has acquired the DIANT® LiFT nanoparticle system for internal research to better understand advanced manufacturing technologies. Our work with the FDA demonstrates that our continuous manufacturing systems with DIANT® Jet technology establishes a leading industry benchmark for nanoparticle manufacture.